The relationship between 3,4-methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid-30s: Findings from the Victorian Adolescent Health Cohort Study

by | Aug 28, 2025 | Uncategorized

Addiction. 2025 Aug 28. doi: 10.1111/add.70173. Online ahead of print. ABSTRACT BACKGROUND AND AIMS: MDMA (3,4-methylenedioxymethamphetamine or “Ecstasy”) is the fourth-most used illicit substance globally. While previous research found links between MDMA...

Electroconvulsive Therapy Variability Across Ontario 2007-2023: A Population Level Study: Variabilité de la thérapie électroconvulsive en Ontario de 2007 à 2023 : une étude au sein de la population

by | Aug 28, 2025 | Uncategorized

Can J Psychiatry. 2025 Aug 28:7067437251371977. doi: 10.1177/07067437251371977. Online ahead of print. ABSTRACT ObjectiveElectroconvulsive therapy (ECT) is an important but underused treatment for severe psychiatric illnesses. We sought to examine the variability of...